Skip to main content
. 2021 Jun 25;11:13314. doi: 10.1038/s41598-021-92533-0

Table 3.

Presenting symptoms.

All patients (n = 164) Patients who did not undergo recanalization(n = 136) Patients with recanalization (n = 28) p-value
Focal symptoms 149 (91) 121 (89) 28 (100) 0.11
Hemiparesis 110 (67) 88 (65) 22 (79) 0.16
Facial weakness 52 (32) 35 (26) 17 (61) < 0.01
Speech disturbance 68 (41) 50 (37) 18 (64) < 0.01
Visual disturbance 32 (20) 29 (21) 3 (11) 0.30
Ataxia 24 (15) 20 (15) 4 (14) 1.00
Paresthesia 19 (12) 17 (13) 2 (7) 0.66
Other focal symptoms 29 (18) 25 (18) 4 (14) 0.84
Nonspecific symptoms 79 (48) 65 (48) 14 (50) 0.83
Headache 39 (34) 30 (22) 9 (32) 0.25
Decreased consciousness level 34 (21) 25 (18) 9 (32) 0.10
Vomiting/nausea 33 (20) 29 (21) 4 (14) 0.61
Vertigo 21 (13) 18 (13) 3 (11) 1.00
Other nonspecific symptoms 5 (3) 5 (4) 0.77
Seizure 30 (18) 27 (20) 3 (11) 0.42

Variables are expressed as n (%); p-values from x2 test or Fisher’s exact test comparing symptoms of patients with RT and symptoms of patients with non-RT.

Presenting symptoms for the whole group (n = 164) and divided by therapy.